James Turley - Precigen Independent Director

Director

Mr. James S. Turley is an Independent Director of Intrexon Corporationrationration, since April 2014. Mr. Turley previously served as the Chairman and Chief Executive Officer of Ernst Young LLP from 2001 until his retirement in June 2013. From 1994 to 2001, Mr. Turley served as Regional Managing Partner of Ernst Young. Mr. Turley serves on the board of directors of Citigroup Inc., a leading global bank, Citibank, N.A., the commercial banking operations of Citigroup Inc., Emerson Electric Co., a global leader in bringing technology and engineering together to provide innovative solutions for customers in industrial, commercial, and consumer markets around the world, and Northrop Grumman Corporation, a leading global security company providing innovative systems, products and solutions to government and commercial customers worldwide. Mr. Turley is also a board member of the Boy Scouts of America, a board member of Kohler Company and a board member of the MUNY Theatre of St. Louis and Theatre Forward. Mr. Turley developed significant expertise in the areas of compensation, litigation, corporate affairs, and corporate governance. Mr. Turley also possesses extensive knowledge and expertise in the areas of financial reporting, business, and risk management. since 2014.
Age 62
Tenure 10 years
Phone301 556-9900
Webwww.dna.com

James Turley Latest Insider Activity

Tracking and analyzing the buying and selling activities of James Turley against Precigen stock is an integral part of due diligence when investing in Precigen. James Turley insider activity provides valuable insight into whether Precigen is net buyers or sellers over its current business cycle. Note, Precigen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Precigen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Precigen Management Efficiency

Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 260.44 M in debt with debt to equity (D/E) ratio of 114.0, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Precigen has a current ratio of 1.88, which is typical for the industry and considered as normal. Debt can assist Precigen until it has trouble settling it off, either with new capital or with free cash flow. So, Precigen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Precigen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Precigen to invest in growth at high rates of return. When we think about Precigen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Diego ApalateguiBBB Foods
47
Yoseph BornsteinMicrobot Medical
65
Scott BurellMicrobot Medical
52
Kim FosterTeleflex Incorporated
68
Faysal KalmouaAlvotech
48
George BabichTeleflex Incorporated
69
Craig HuffAspen Aerogels
49
Alejandro DavilaBBB Foods
46
Rebecca BlalockAspen Aerogels
63
Richard PackerTeleflex Incorporated
62
Diane OwenLB Foster
62
Daniel SmithSimon Property Group
63
Suzanne RowlandLB Foster
56
Robert GervisAspen Aerogels
58
Martin MaddenMicrobot Medical
57
Karen HornSimon Property Group
77
Yoav WaizerMicrobot Medical
51
Ramsay BattinAspen Aerogels
43
Larry GlasscockSimon Property Group
72
Robert PurgasonLB Foster
62
Albert SmithSimon Property Group
77
Precigen, Inc. engages in the engineering and industrialization of biology in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. Intrexon is traded on NASDAQ in USA. Precigen (XON) is traded on NASDAQ Exchange in USA and employs 770 people.

Management Performance

Precigen Leadership Team

Elected by the shareholders, the Precigen's board of directors comprises two types of representatives: Precigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precigen. The board's role is to monitor Precigen's management team and ensure that shareholders' interests are well served. Precigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven Frank, Independent Director
Robert Walsh, Senior Vice President - Energy and Chemicals Sector
Thomas Kasser, Senior Vice President - Food Sector
Corey Huck, senior Vice President Food Sector
Gregory Frost, Sr. VP of Health Sector
Randal Kirk, Chairman of the Board, CEO
Andrew Last, COO
Christopher Basta, Vice President - Investor Relations
Rick Sterling, CFO
Krish Krishnan, COO
Cesar Alvarez, Independent Director
Donald Lehr, Chief Legal Officer
Joseph Vaillancourt, Senior Vice President Environment Sector
Jeffrey Perez, Senior Vice President — Intellectual Property Affairs
Joel Liffmann, Senior Vice President - Finance
Helen Sabzevari, President of Precigen, Inc.
Dean Mitchell, Independent Director
Robert Shapiro, Independent Director
Geno Germano, President
Jeffrey Kindler, Independent Director
Jack Bobo, Senior Vice President Chief Communications Officer
Ena Cratsenburg, Senior Vice President - Consumer Sector
Thomas Bostick, COO
Samuel Broder, Executive Vice President - Scientific and Public Affairs
Suma Krishnan, Senior Vice President - Product Development
Vinita Gupta, Director
Fred Hassan, Director
James Turley, Independent Director
Darryl Webster, Senior Vice President - Intellectual Property
Nir Nimrodi, Sr. VP of Corporate Devel. and Environment Sector
Thomas Reed, Founder and Chief Science Officer

Precigen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Precigen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Precigen's short interest history, or implied volatility extrapolated from Precigen options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Consideration for investing in Precigen Stock

If you are still planning to invest in Precigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Precigen's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges